Trial Profile

A pivotal randomized clinical trial of IB-1000 for inherited Cerebellar Ataxia (CA) diseases

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 26 Nov 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Acetylleucine (Primary)
Indications Cerebellar ataxia
Focus Registrational; Therapeutic Use

Most Recent Events

26 Nov 2018 New trial record
15 Sep 2017 According to an IntraBio media release, the company expects to commence enrollment in the trial in the EU starting enrollment by early 2018 to be followed by recruitment in North America. The company will provide full details of the clinical trial, including inclusion criteria, as soon as they are available.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com